Pealkiri: 

10-year serological follow-up of celiac disease in an Estonian population

Autorid: Lillemäe K , Ress K , Harro J , Merenäkk L , Maaroos H-I , Uibo R , Uibo O
Väljaandja/tellija: Eur J Gastroenterol Hepatol
Märksõnad: mittenakkushaigused, lapsed, toitumine, haigestumus
Välja antud: 2012
Tüüp: Teaduslik artikkel/kogumik
Viide: Lillemäe K, Ress K, Harro J, et al. A 10-year serological follow-up of celiac disease in an Estonian population. Eur J Gastroenterol Hepatol 2012;24(1):55-58.
Alamvaldkonnad:Mittenakkushaigused
Kirjeldus: BACKGROUND:
Celiac disease (CD) is induced by wheat gluten and related prolamines. Its prevalence may be underestimated in many geographic regions and populations, and has recently increased in several countries. In 1998 and 1999, a random sample of Estonian schoolchildren was screened with IgA-type tissue transglutaminase antibodies (IgA-tTG) for CD. The results revealed a CD prevalence of 0.34%, which is lower compared with many other European countries.
OBJECTIVE:
We rescreened the same population for CD using IgA-tTG after a 10-year interval.
MATERIALS AND METHODS:
A total of 891 patients from the initial sample were rescreened using the IgA-tTG assay for a participation rate of 76.8% (median age, 24.3 years). As in the initial study, the IgA-tTG results were evaluated by ImmunoCAP EliA Celikey using an IgG-tTG and deamidated gliadin antibody assay for IgA-deficient cases.
RESULTS:
No new cases of CD were found in this follow-up study. Of note, 75% of patients with initial IgA-tTG-positive results and biopsy-proven CD remained seropositive. One patient with a negative seroconversion at the time of rescreening followed a strict gluten-free diet during the follow-up years.
CONCLUSION:
In a 10-year follow-up period, no new cases of CD were found in this Estonian population of school-children and young adults. Therefore, we presume no increase in CD during the last decade among this age group in Estonia. Additional studies are needed to determine whether similar results would be obtained in other age groups, because of differences in the CD prevalence between Estonian and other European populations.